NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a leading biotechnology company focused on developing cell and gene therapies for aging and age-related diseases, ...
InvestorsHub on MSN
Klotho Neurosciences advances epigenetic diagnostics with development of AI-driven "Klotho Clock"
Klotho Neurosciences, Inc. (NASDAQ:KLTO) announced the launch of a new genomics diagnostics initiative centered on two epigenetics-based tests designed to support its clinical trials and expand ...
Review explores the connection between gene length and aging, summarizing recent findings that link reduced long-gene expression to age-related decline and potential anti-aging strategies. Review: ...
Hosted on MSN
Billionaires chase immortality as Harvard-backed startup wins FDA nod for 1st partial de-aging trial
The race to slow, halt, or even reverse aging has moved from science fiction into the regulatory record. A Harvard-linked startup, Life Biosciences, has secured clearance from the U.S. Food and Drug ...
When scientists want to study aging and how to slow it down, they often turn to microscopic worms or lab mice among other models. The former are too different from humans, while the latter are ...
Scientists in Europe have discovered that a specific anti-aging drug mix can significantly extend the lifespan of mice while also improving their overall health. The combination involves two drugs, ...
In pre-clinical trials, a small molecule effectively regrew neurons, reduced inflammation, and improved memory, speed, coordination, grip strength, and more. The finding could have a profound impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results